(Q38745381)

6 September 2017

Glucocorticoid-induced fetal origins of adult hypertension: Association with epigenetic events (English)

1 reference

6 September 2017

M Akhtar Anwar

1

1 reference

6 September 2017

Alaaeldin I Saleh

2

1 reference

6 September 2017

Reem Al Olabi

3

1 reference

6 September 2017

Tuqa S Al Shehabi

4

1 reference

6 September 2017

Ali H Eid

5

1 reference

6 September 2017

19 February 2016

1 reference

6 September 2017

Vascular Pharmacology

1 reference

6 September 2017

82

1 reference

6 September 2017

41-50

1 reference

Cortisol metabolism in hypertension

6 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Glucocorticoids and the cardiovascular system: state of the art.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Overview: mechanisms of hypertension: cells, hormones, and the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Epigenetic therapy for solid tumors: from bench science to clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Epigenetics and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Influence of hydrocortisone on cardiovascular responses to epinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

In utero programming of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Glucocorticoids, prenatal stress and the programming of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Non-genomic effect of glucocorticoids on cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Prenatal treatment with glucocorticoids sensitizes the hpa axis response to stress among full-term infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Programming the cardiovascular system, kidney and the brain--a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Synthesis of corticosterone in the vascular wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Hypertension and the cortisol-cortisone shuttle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Adipose tissue expression of 11beta-hydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Potentiation of smooth muscle contraction by adrenal steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Potentiation of angiotensin II action by corticosteroids in vascular tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

11 beta-Hydroxysteroid dehydrogenase antisense affects vascular contractile response and glucocorticoid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11beta-hydroxysteroid dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Chronic inhibition of 11 β -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Apparent mineralocorticoid excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Apparent mineralocorticoid excess in a Brazilian kindred

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Programming of hypertension: associations of plasma aldosterone in adult men and women with birthweight, cortisol, and blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

The associations of high birth weight with blood pressure and hypertension in later life: a systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Birth weight and subsequent blood pressure: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Association between postnatal catch-up growth and obesity in childhood: prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Birth weight and infant growth: optimal infant weight gain versus optimal infant weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Fetal origin of childhood disease: intrauterine growth restriction in term infants and risk for hypertension at 6 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Association between umbilical cord glucocorticoids and blood pressure at age 3 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Fetal programming alters reactive oxygen species production in sheep cardiac mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Impact of oxidative stress in fetal programming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Early gestation dexamethasone programs enhanced postnatal ovine coronary artery vascular reactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Increased adiposity in annexin A1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Ac2-26 Mimetic Peptide of Annexin A1 Inhibits Local and Systemic Inflammatory Processes Induced by Bothrops moojeni Venom and the Lys-49 Phospholipase A2 in a Rat Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Dysregulation of anti-inflammatory annexin A1 expression in progressive Crohns Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Inflammation, immunity, and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Oxidative stress and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Reactive oxygen species in vascular biology: implications in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Redox signaling, Nox5 and vascular remodeling in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Dexamethasone induced alterations in enzymatic and nonenzymatic antioxidant status in heart and kidney of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Vascular NADPH oxidases: molecular mechanisms of activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Oxidant stress from uncoupled nitric oxide synthase impairs vasodilation in fetal lambs with persistent pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Rescue Treatment with L-Citrulline Inhibits Hypoxia-Induced Pulmonary Hypertension in Newborn Pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Effects of sepiapterin supplementation and NOS inhibition on glucocorticoid-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Effects of oral L-arginine on plasma nitrate and blood pressure in cortisol-treated humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Dexamethasone lacks effect on blood pressure in mice with a disrupted endothelial NO synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

The nitric oxide system and cortisol-induced hypertension in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Vascular inflammatory cells in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Cortisol inhibits cholinergic vasodilation in the human forearm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotropin-induced and corticosterone-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Hypertension in mice lacking the gene for endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

The microvasculature: a target for nutritional programming and later risk of cardio-metabolic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Rho kinase inhibition mitigates sunitinib-induced rise in arterial pressure and renal vascular resistance but not increased renal sodium reabsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Novel ROCK inhibitors for the treatment of pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Sustained elevation of serum cortisol level causes sensitization of coronary vasoconstricting responses in pigs in vivo: a possible link between stress and coronary vasospasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Evaluation and treatment of Cushing's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Rho-Kinase activity and cutaneous vasoconstriction is upregulated in essential hypertensive humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Arginase 1 mediates increased blood pressure and contributes to vascular endothelial dysfunction in deoxycorticosterone acetate-salt hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Genomic and nongenomic effects of glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Zap70 signaling pathway mediates glucocorticoid receptor-dependent transcriptional activation: role in the regulation of annexin 1 expression in T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Enhanced anti-inflammatory potency of a nitric oxide-releasing derivative of flunisolide: role of nuclear factor-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Dexamethasone induces rapid promotion of norepinephrine‑mediated vascular smooth muscle cell contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Glucocorticoid-related signaling effects in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

A role for MAP kinase in differentiated smooth muscle contraction evoked by alpha-adrenoceptor stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

High-expression of transforming growth factor beta1 and phosphorylation of extracellular signal-regulated protein kinase in vascular smooth muscle cells from aorta and renal arterioles of spontaneous hypertension rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Introduction: diet, epigenetic events and cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Placental epigenetic patterning of glucocorticoid response genes is associated with infant neurodevelopment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Long-term effects of prenatal stress on HPA axis activity in juvenile rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Epigenetic programming by maternal behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Early onset pre-eclampsia is associated with altered DNA methylation of cortisol-signalling and steroidogenic genes in the placenta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Associations between DNA methylation of a glucocorticoid receptor promoter and acute stress responses in a large healthy adult population are largely explained by lifestyle and educational differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Promoter methylation of glucocorticoid receptor gene is associated with subclinical atherosclerosis: A monozygotic twin study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Epigenetic regulation of the placental HSD11B2 barrier and its role as a critical regulator of fetal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Epigenetic effects of prenatal stress on 11β-hydroxysteroid dehydrogenase-2 in the placenta and fetal brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

An unbalanced maternal diet in pregnancy associates with offspring epigenetic changes in genes controlling glucocorticoid action and foetal growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

A calcium-deficient diet in pregnant, nursing rats induces hypomethylation of specific cytosines in the 11β-hydroxysteroid dehydrogenase-1 promoter in pup liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Cardiovascular consequences of cortisol excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Critical role of histone acetylation by p300 in human placental 11β-HSD2 expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Redox regulation of SIRT1 in inflammation and cellular senescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

SIRT1 and Connexin40 Mediate the normal shear stress-induced inhibition of the proliferation of endothelial cells co-cultured with vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

SIRT1 contributes to telomere maintenance and augments global homologous recombination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Telomeres and cardiovascular disease: does size matter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Targeting cardiovascular disease with novel SIRT1 pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Glucocorticoid dysregulation of natural killer cell function through epigenetic modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Interferon gamma attenuates hypertensive renal injury in salt-sensitive Dahl rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Implications of abnormal glucose metabolism in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

HDAC inhibition: A novel therapeutic target for attenuating pulmonary hypertension by regulating Tregs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

HDAC inhibition: A novel therapeutic target for pulmonary hypertension by reducing right ventricular hypertrophy through diverse pathological mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Control of translation and mRNA degradation by miRNAs and siRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Glucocorticoid hormones decrease proliferation of embryonic neural stem cells through ubiquitin-mediated degradation of cyclin D1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

ACTH-Dependent Regulation of MicroRNA As Endogenous Modulators of Glucocorticoid Receptor Expression in the Adrenal Gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Mechanisms and therapeutic potential of microRNAs in hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Modulation of miRNAs in Pulmonary Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Is prenatal glucocorticoid administration another origin of adult disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

Prenatal glucocorticoids and long-term programming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2016.02.002

10.1016/J.VPH.2016.02.002

7 January 2021

Identifiers

DOI

1 reference

6 September 2017

1 reference